Last updated 32 days ago
A Study to Evaluate Effectiveness and Safety of Deucravacitinib in Participants With Non-Pustular Palmoplantar and Genital Psoriasis
360 patients around the world
Available in Spain, United States, Argentina
Bristol-Myers Squibb
1Research sites
360Patients around the world
This study is for people with
Psoriasis
Palmar-plantar psoriasis
Requirements for the patient
From 18 Years
All Gender
Medical requirements
- Inclusion Criteria for Non-Pustular Palmoplantar PsoriasisInclusion Criteria for Genital Psoriasis
- Target Disease Exceptions
Sites
Psoriahue Medicina Interdisciplinaria - CABA, Buenos Aires
Recruiting
SponsorBristol-Myers Squibb
Conditions
Palmar-plantar psoriasis
Requirements
From 18 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT06042920
